A human epidermal growth factor receptor 3 (HER3)-binding nanoparticle targets and kills Herceptin®-resistant human epidermal growth factor receptor 2 (HER2)-positive breast cancer

被引：1
|
作者：
Sims, J. D.
Taguaim, M.
Hanson, C.
Cui, X.
Medina-Kauwe, L. K.
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P5-08-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-08-08
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The human epidermal growth factor receptor 2 (HER2)
    Tafe, Laura J.
    Tsongalis, Gregory J.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (01) : 23 - 30
  • [2] Human epidermal growth factor receptor 2/3 (HER2/HER3) expression in higher-grade meningioma
    Mair, Maximilian
    Tomasich, Erwin
    Paiato, Christina
    Widhalm, Georg
    Eckert, Franziska
    Sahm, Felix
    Hainfellner, Johannes A.
    Berghoff, Anna Sophie
    Preusser, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Investigation of Affinity at Binding Site Between Human Epidermal Growth Factor Receptor 2 (HER2) and Herceptin
    Kondrashova, Maria
    Miller, Bill
    FASEB JOURNAL, 2017, 31
  • [4] Clinical impact of epidermal growth factor receptor (EGFR) coexpression in early breast cancer with human epidermal growth factor receptor 2 (HER2) overexpression
    Park, S.
    Cho, E.
    Shin, Y.
    Hong, S.
    Lee, M.
    Park, Y.
    Nam, S.
    Yang, J.
    Choi, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Targeting the Human Epidermal Growth Factor Receptor Family in Breast Cancer beyond HER2
    Riecke, Kerstin
    Witzel, Isabell
    BREAST CARE, 2020, 15 (06) : 579 - 585
  • [6] Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: Quantitative analysis of HER2 overexpression effects
    Hendriks, BS
    Opresko, LK
    Wiley, HS
    Lauffenburger, D
    CANCER RESEARCH, 2003, 63 (05) : 1130 - 1137
  • [7] Managing metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer in the older patient
    Freedman, Rachel A.
    Muss, Hyman B.
    JOURNAL OF GERIATRIC ONCOLOGY, 2014, 5 (01) : 2 - 7
  • [8] A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion
    Fichter, Christiane Daniela
    Przypadlo, Camilla Maria
    Buck, Achim
    Herbener, Nicola
    Riedel, Bianca
    Schaefer, Luisa
    Nakagawa, Hiroshi
    Walch, Axel
    Reinheckel, Thomas
    Werner, Martin
    Lassmann, Silke
    JOURNAL OF PATHOLOGY, 2017, 243 (04): : 481 - 495
  • [9] Controversies of radiotherapy in human epidermal growth factor receptor (HER)-2 positive breast cancer patients
    Kolarova, Iveta
    Melichar, Bohuslav
    Vanasek, Jaroslav
    Ryska, Ales
    Horackova, Katerina
    Petera, Jiri
    Vosmik, Milan
    Sirak, Igor
    Dolezel, Martin
    BIOMEDICAL PAPERS-OLOMOUC, 2021, 165 (01): : 19 - 25
  • [10] Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer
    Siena, S.
    Sartore-Bianchi, A.
    Marsoni, S.
    Hurwitz, H. I.
    McCall, S. J.
    Penault-Llorca, F.
    Srock, S.
    Bardelli, A.
    Trusolino, L.
    ANNALS OF ONCOLOGY, 2018, 29 (05) : 1108 - 1119
12345